Yorke Justin W. - 27 Jan 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jan 2025
Net transactions value
+$9,889
Form type
4
Filing time
31 Jan 2025, 17:06:27 UTC
Previous filing
18 Sep 2024
Next filing
18 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $9,889 +12,400 $0.7975 12,400 27 Jan 2025 By Directed Trust Company FBO Justin Yorke IRA
holding PCSA Common Stock 31,232 27 Jan 2025 By Richland Fund, LLC
holding PCSA Common Stock 3,737 27 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.